The GOLD Study: G8 in OLDer Patients

Active, not recruitingOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

October 26, 2017

Primary Completion Date

February 7, 2022

Study Completion Date

July 31, 2024

Conditions
Elderly Metastatic Colorectal Cancer Patients
Trial Locations (1)

35128

Istituto Oncologico Veneto IRCCS, Padua

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Istituto Oncologico Veneto IRCCS

OTHER

NCT03449914 - The GOLD Study: G8 in OLDer Patients | Biotech Hunter | Biotech Hunter